• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆因子 XIII 四聚体复合物结构:在对称复合物中出现意想不到的不等配对。

The Plasma Factor XIII Heterotetrameric Complex Structure: Unexpected Unequal Pairing within a Symmetric Complex.

机构信息

Institute of Experimental Hematology and Transfusion medicine, University Hospital of Bonn, Sigmund-Freud Street 25, 53127 Bonn, Germany.

CovalX, Schützengasse 2, CH-8001 Zürich, Switzerland.

出版信息

Biomolecules. 2019 Nov 21;9(12):765. doi: 10.3390/biom9120765.

DOI:10.3390/biom9120765
PMID:31766577
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6995596/
Abstract

Factor XIII (FXIII) is a predominant determinant of clot stability, strength, and composition. Plasma FXIII circulates as a pro-transglutaminase with two catalytic A subunits and two carrier-protective B subunits in a heterotetramer (FXIII-AB). FXIII-A and -B subunits are synthesized separately and then assembled in plasma. Following proteolytic activation by thrombin and calcium-mediated dissociation of the B subunits, activated FXIII (FXIIIa) covalently cross links fibrin, promoting clot stability. The zymogen and active states of the FXIII-A subunits have been structurally characterized; however, the structure of FXIII-B subunits and the FXIII-AB complex have remained elusive. Using integrative hybrid approaches including atomic force microscopy, cross-linking mass spectrometry, and computational approaches, we have constructed the first all-atom model of the FXIII-AB complex. We also used molecular dynamics simulations in combination with isothermal titration calorimetry to characterize FXIII-AB assembly, activation, and dissociation. Our data reveal unequal pairing of individual subunit monomers in an otherwise symmetric complex, and suggest this unusual structure is critical for both assembly and activation of this complex. Our findings enhance understanding of mechanisms associating FXIII-AB mutations with disease and have important implications for the rational design of molecules to alter FXIII assembly or activity to reduce bleeding and thrombotic complications.

摘要

凝血因子 XIII(FXIII)是决定血栓稳定性、强度和组成的主要因素。血浆 FXIII 以具有两个催化 A 亚基和两个载体保护 B 亚基的前转谷氨酰胺酶形式循环,形成四聚体(FXIII-AB)。FXIII-A 和 -B 亚基分别合成,然后在血浆中组装。在凝血酶的蛋白水解激活和钙介导的 B 亚基解离后,激活的 FXIII(FXIIIa)共价交联纤维蛋白,促进血栓稳定性。FXIII-A 亚基的酶原和活性状态已得到结构表征;然而,FXIII-B 亚基和 FXIII-AB 复合物的结构仍然难以捉摸。我们使用整合的混合方法,包括原子力显微镜、交联质谱和计算方法,构建了 FXIII-AB 复合物的第一个全原子模型。我们还使用分子动力学模拟结合等温滴定量热法来表征 FXIII-AB 的组装、激活和解离。我们的数据揭示了在对称复合物中单个亚基单体的不等配对,并且表明这种不寻常的结构对于该复合物的组装和激活都是至关重要的。我们的研究结果增强了对与 FXIII-AB 突变相关疾病的机制的理解,并对改变 FXIII 组装或活性以减少出血和血栓并发症的分子的合理设计具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf97/6995596/b7f5ae586d6c/biomolecules-09-00765-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf97/6995596/e1b78e2e634b/biomolecules-09-00765-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf97/6995596/d824617f6730/biomolecules-09-00765-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf97/6995596/34f18510fd57/biomolecules-09-00765-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf97/6995596/4c9d2480c839/biomolecules-09-00765-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf97/6995596/28af6d520d26/biomolecules-09-00765-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf97/6995596/f2c76aa73c88/biomolecules-09-00765-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf97/6995596/b7f5ae586d6c/biomolecules-09-00765-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf97/6995596/e1b78e2e634b/biomolecules-09-00765-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf97/6995596/d824617f6730/biomolecules-09-00765-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf97/6995596/34f18510fd57/biomolecules-09-00765-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf97/6995596/4c9d2480c839/biomolecules-09-00765-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf97/6995596/28af6d520d26/biomolecules-09-00765-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf97/6995596/f2c76aa73c88/biomolecules-09-00765-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf97/6995596/b7f5ae586d6c/biomolecules-09-00765-g007.jpg

相似文献

1
The Plasma Factor XIII Heterotetrameric Complex Structure: Unexpected Unequal Pairing within a Symmetric Complex.血浆因子 XIII 四聚体复合物结构:在对称复合物中出现意想不到的不等配对。
Biomolecules. 2019 Nov 21;9(12):765. doi: 10.3390/biom9120765.
2
Factor XIII topology: organization of B subunits and changes with activation studied with single-molecule atomic force microscopy.因子 XIII 拓扑结构:用单分子原子力显微镜研究 B 亚基的组织和激活时的变化。
J Thromb Haemost. 2019 May;17(5):737-748. doi: 10.1111/jth.14412. Epub 2019 Mar 14.
3
Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function.凝血因子 XIII 的新特性。I. 结构、分布、激活及功能。
Crit Rev Clin Lab Sci. 1996;33(5):357-421. doi: 10.3109/10408369609084691.
4
The interaction between fibrinogen and zymogen FXIII-A2B2 is mediated by fibrinogen residues γ390-396 and the FXIII-B subunits.纤维蛋白原与酶原FXIII - A2B2之间的相互作用由纤维蛋白原残基γ390 - 396和FXIII - B亚基介导。
Blood. 2016 Oct 13;128(15):1969-1978. doi: 10.1182/blood-2016-04-712323. Epub 2016 Aug 25.
5
Antibodies against Noncatalytic B Subunit of Factor XIII Inhibit Activation of Factor XIII and Fibrin Crosslinking.抗因子 XIII 非催化 B 亚单位抗体抑制因子 XIII 的活化和纤维蛋白交联。
Thromb Haemost. 2023 Sep;123(9):841-854. doi: 10.1055/a-2057-8710. Epub 2023 Mar 19.
6
The Non-catalytic B Subunit of Coagulation Factor XIII Accelerates Fibrin Cross-linking.凝血因子 XIII 的非催化 B 亚基可加速纤维蛋白交联。
J Biol Chem. 2015 May 8;290(19):12027-39. doi: 10.1074/jbc.M114.608570. Epub 2015 Mar 25.
7
Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.转谷氨酰胺酶(因子 XIII)介导的纤维蛋白原和纤维蛋白交联。
Thromb Haemost. 2001 Nov;86(5):1221-8.
8
Structure functional insights into calcium binding during the activation of coagulation factor XIII A.在凝血因子 XIII A 激活过程中钙结合的结构功能见解。
Sci Rep. 2019 Aug 5;9(1):11324. doi: 10.1038/s41598-019-47815-z.
9
Activation of factor XIII is accompanied by a change in oligomerization state.因子 XIII 的激活伴随着寡聚化状态的改变。
FEBS J. 2017 Nov;284(22):3849-3861. doi: 10.1111/febs.14272. Epub 2017 Oct 3.
10
Interaction of factor XIII subunits.因子 XIII 亚基的相互作用。
Blood. 2014 Mar 13;123(11):1757-63. doi: 10.1182/blood-2013-10-533596. Epub 2014 Jan 9.

引用本文的文献

1
Another cryo-EM success: structure of FXIII.冷冻电镜的又一成功:凝血因子 XIII 的结构
Blood. 2025 Jan 23;145(4):356-357. doi: 10.1182/blood.2024027405.
2
Reciprocal stabilization of coagulation factor XIII-A and -B subunits is a determinant of plasma FXIII concentration.凝血因子 XIII-A 和 -B 亚基的相互稳定是血浆 FXIII 浓度的决定因素。
Blood. 2024 Feb 1;143(5):444-455. doi: 10.1182/blood.2023022042.
3
Antioxidant role of methionine-containing intra- and extracellular proteins.含蛋氨酸的细胞内和细胞外蛋白质的抗氧化作用。

本文引用的文献

1
Factor XIII topology: organization of B subunits and changes with activation studied with single-molecule atomic force microscopy.因子 XIII 拓扑结构:用单分子原子力显微镜研究 B 亚基的组织和激活时的变化。
J Thromb Haemost. 2019 May;17(5):737-748. doi: 10.1111/jth.14412. Epub 2019 Mar 14.
2
Structure and functional interactions of INO80 actin/Arp module.INO80 肌动蛋白/Arp 模块的结构与功能相互作用。
J Mol Cell Biol. 2019 May 1;11(5):345-355. doi: 10.1093/jmcb/mjy062.
3
Chemical Crosslinking Mass Spectrometry Reveals the Conformational Landscape of the Activation Helix of PPARγ; a Model for Ligand-Dependent Antagonism.
Biophys Rev. 2023 Apr 10;15(3):367-383. doi: 10.1007/s12551-023-01056-7. eCollection 2023 Jun.
4
Exploring Diverse Coagulation Factor XIII Subunit Expression Datasets: A Bioinformatic Analysis.探索多样化的凝血因子 XIII 亚单位表达数据集:一项生物信息学分析。
Int J Mol Sci. 2022 Apr 25;23(9):4725. doi: 10.3390/ijms23094725.
5
Functional and Structural Characterization of Nucleic Acid Ligands That Bind to Activated Coagulation Factor XIII.与活化凝血因子XIII结合的核酸配体的功能与结构表征
J Clin Med. 2021 Feb 10;10(4):677. doi: 10.3390/jcm10040677.
6
NMR-Based Structural Characterization of a Two-Disulfide-Bonded Analogue of the FXIIIa Inhibitor Tridegin: New Insights into Structure-Activity Relationships.基于 NMR 的 FXIIIa 抑制剂 Tridegin 的二硫键结合类似物的结构特征:对结构-活性关系的新见解。
Int J Mol Sci. 2021 Jan 17;22(2):880. doi: 10.3390/ijms22020880.
7
The Structure of Blood Coagulation Factor XIII Is Adapted to Oxidation.凝血因子 XIII 结构适应氧化。
Biomolecules. 2020 Jun 17;10(6):914. doi: 10.3390/biom10060914.
化学交联质谱揭示了 PPARγ 激活螺旋的构象景观;配体依赖性拮抗作用的模型。
Structure. 2018 Nov 6;26(11):1431-1439.e6. doi: 10.1016/j.str.2018.07.007. Epub 2018 Aug 23.
4
Fibrinogen and factor XIII: newly recognized roles in venous thrombus formation and composition.纤维蛋白原和因子 XIII:在静脉血栓形成和组成中的新认识作用。
Curr Opin Hematol. 2018 Sep;25(5):358-364. doi: 10.1097/MOH.0000000000000445.
5
Defining distance restraints in HADDOCK.在HADDOCK中定义距离约束。
Nat Protoc. 2018 Jul;13(7):1503. doi: 10.1038/s41596-018-0017-6. Epub 2018 Jun 25.
6
Purification and Characterization of Low-n Tau Oligomers.低n Tau寡聚体的纯化与表征
Methods Mol Biol. 2018;1779:99-111. doi: 10.1007/978-1-4939-7816-8_8.
7
A home for integrative structural models.整合结构模型之家。
Nat Methods. 2018 Jun;15(6):409. doi: 10.1038/s41592-018-0032-0.
8
Modeling Protein Complexes Using Restraints from Crosslinking Mass Spectrometry.利用交联质谱的约束条件构建蛋白质复合物模型。
Structure. 2018 Jul 3;26(7):1015-1024.e2. doi: 10.1016/j.str.2018.04.016. Epub 2018 May 24.
9
Activation of factor XIII is accompanied by a change in oligomerization state.因子 XIII 的激活伴随着寡聚化状态的改变。
FEBS J. 2017 Nov;284(22):3849-3861. doi: 10.1111/febs.14272. Epub 2017 Oct 3.
10
PDB-Dev: a Prototype System for Depositing Integrative/Hybrid Structural Models.PDB-Dev:用于提交整合/混合结构模型的原型系统。
Structure. 2017 Sep 5;25(9):1317-1318. doi: 10.1016/j.str.2017.08.001.